Compare Extra Space Storage, Inc. (EXR) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Tango Therapeutics Inc. — how do they compare? Extra Space Storage, Inc. trades at $135.18 (market cap $28.26B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B). The key difference: Extra Space Storage, Inc. is far larger — about 7.5× Tango Therapeutics Inc.'s market cap, and Extra Space Storage, Inc. pays a 4.85% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and Tango Therapeutics Inc. for 0 Days on average.
| EXR | TNGX | |
|---|---|---|
Market Cap | $28.26B | $3.75B |
Volume | 1,443,466 | 9,619,106 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $32.90 |
52-Week Low | $126.67 | $7.50 |
Typical Hold Time | 109 Days | 0 Days |
Enterprise Value | $41.97B | $2.77B |
Dividend Yield | 4.85% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Extra Space Storage (EXR) trades at $134.06, up slightly by 0.01% today, with a neutral technical signal and bearish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38 billion in 2025, and net income reached $974 million, supported by a robust gross margin of 70.78%. Analyst consensus is evenly split between Buy and Hold, with a price target of $158.33, suggesting potential upside. Recent news highlights leadership transitions and steady dividend payments.
Outlook: EXR shows solid operational performance and financial flexibility, but faces risks from high leverage and softer housing demand. The stock's valuation metrics like P/E of 29.52 and EV/EBITDA of 17.35 indicate premium pricing. Investment opportunity lies in sustained earnings growth and dividend yield, while risks include interest rate sensitivity and competitive pressures in the REIT sector.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
